John McHutchison AO, MD
Chief Scientific Officer, Head of Research and Development

Dr. McHutchison joined Gilead in 2010, and was appointed Chief Scientific Officer in March 2018. Prior to joining Gilead, Dr. McHutchison worked at Duke University Medical Center, where he served as Associate Director of the Duke Clinical Research Institute. He also held the positions of Professor of Medicine in the Division of Gastroenterology at Duke University Medical Center, Associate Director at Duke Clinical Research Institute and Co-Director of the Duke Clinical and Translational Science Award. Prior to his positions at Duke, Dr. McHutchison spent nearly 10 years at Scripps Clinic, most recently as Medical Director, Liver Transplantation. He also previously held an Assistant Professorship in Medicine at the University of Southern California.
In June 2018, Dr. McHutchison was appointed an Officer of the Order of Australia in recognition of his distinguished service to medical research in gastroenterology and hepatology.
Dr. McHutchison has undergraduate degrees in medicine and surgery from the University of Melbourne in Australia and completed his residency in internal medicine and fellowship in gastroenterology at the Royal Melbourne Hospital. He is a member of the Royal Australasian College of Physicians.
Senior Management
-
Gregg H. Alton
Interim Chief Executive Officer and Chief Patient Officer
-
Andrew Dickinson
Executive Vice President, Corporate Development and Strategy
-
Laura Hamill
Executive Vice President, Worldwide Commercial Operations
-
William A. Lee, PhD
Executive Vice President, Research
-
John McHutchison AO, MD
Chief Scientific Officer, Head of Research and Development
-
Brett A. Pletcher
Executive Vice President, General Counsel and Chief Compliance Officer
-
Alessandro Riva, MD
Executive Vice President, Oncology Therapeutics
-
Robin L. Washington
Executive Vice President and Chief Financial Officer
-
Katie L. Watson
Executive Vice President, Human Resources
-
Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing
Board of Directors
-
John C. Martin, PhD
Chairman of the Board of Directors
-
Jacqueline K. Barton, PhD
Professor, California Institute of Technology
-
John F. Cogan, PhD
Lead Independent Director, Gilead Sciences
-
Kelly A. Kramer
Executive Vice President and Chief Financial Officer, Cisco Systems, Inc.
-
Kevin E. Lofton
Chief Executive Officer, Catholic Health Initiatives
-
Harish Manwani
Retired Chief Operating Officer, Unilever
-
George P. Shultz
Director Emeritus, Gilead Sciences
-
Richard J. Whitley, MD
Distinguished Professor, Loeb Scholar Chair in Pediatrics, Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery, University of Alabama at Birmingham
-
Gayle Edlund Wilson
Chairman Emeritus of COSMOS, The California State Summer School for Math and Science
-
Per Wold-Olsen
Retired President, Human Health Intercontinental Division, Merck & Co., Inc.